欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/4535/005
药品名称Gaviscon Double Action Mixed Berries Flavour Chewable Tablets
活性成分
    • Calcium carbonate 187.5 mg
    • Sodium alginate 250.0 mg
    • sodium hydrogen carbonate 106.5 mg
剂型Chewable tablet
上市许可持有人Reckitt Benckiser Healthcare B.V. Siriusdreef 14 2132 WT Hoofddorp The Netherlands
参考成员国 - 产品名称Netherlands (NL)
Gaviscon Duo bosvruchtensmaak 250 mg/106,5 mg/187,5 mg kauwtabletten
互认成员国 - 产品名称
    • Cyprus (CY)
      GAVISCON DOUBLE ACTION Mixed Berries 250/106.50/187.50mg μασώμενο δισκίο
    • Italy (IT)
    • Greece (GR)
许可日期2024/12/13
最近更新日期2025/07/08
药物ATC编码
    • A02BX Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Bibliographic Art 10 a Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Non Prescription (including OTC)
附件文件下载
    市场状态Positive
    ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase